Nov. 02, 2012
Posted at November 2, 2012 7:37 pm by E. Michael D. (Mike) Scott

One Response to Glybera Becomes First-ever Gene Therapy Approved in Europe

  1. Sue Kahn says:

    The National Tay-Sachs & Allied Diseases Association (NTSAD) is very excited about this approval because we are hopeful that a Tay-Sachs gene therapy human clinical trial will begin in March, 2013. I can be contacted at skahn@ntsad.org for further information.

Leave a Reply

*

EURORDISRare Disease Day USNORD